53

Zenlabs Ethica LtdBOM 530697 Stock Report

Last reporting period 30 Sep, 2023

Updated 31 Oct, 2024

Last price

Market cap $B

0.002

Micro

Exchange

XBOM - Bombay Stock Exchange

530697.BO Stock Analysis

53

Uncovered

Zenlabs Ethica Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-5/100

Low score

Market cap $B

0.002

Dividend yield

0.52 %

Shares outstanding

6.51 B

Zenlabs Ethica Ltd. engages in trading of pharmaceutical products. The company is headquartered in Chandigarh, Chandigarh. The firm is engaged in trading in a range of branded drugs, including gastrointestinal tract disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps and anti-bacterial drugs, nutraceuticals, and other. The company has approximately five manufacturing units. The company operates through three divisions: Zenlabs, Coles Pharma and Mega Star. Zenlabs division provides various products, including Analgesics & Anti-Inflammatory, Skin Preparations, Neurological Disorders, Eye, Ear and Nasal Drops, Anti-Diabetic, Anti-Depressant, Anti-Infective, Anti-Emetic, Steroid & Anabolic Steroid, Anti-Hypertensive Drugs, Anti Allergic, Anti Cold & Cough Syrup, Nutraceuticals, Antacid, Enzymes & Appetite Stimulant, Ayurvedic Preparation, GIT Disorders, Soap, and Other Pharmaceutical Drugs. Coles Pharma division provides various products, including Analgesics & Anti-Inflammatory, Nutraceuticals, Skin Preparations, and other.

View Section: Eyestock Rating